Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Havrix concomitant administration with Infanrix and ActHIB in healthy 15-month-old children
2015-001530-25Phase 3
- Sponsor
- GSK
- Start
- Jun 2015
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes, Whole Inactivated Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of Hepatitis A virus vaccine, acellular pertussis vaccine and haemophilus influenzae type b vaccine in hepatitis A (HAV), diphtheria, Tetanus and 2 more (3 arms), sponsored by GSK. Primary endpoints: Anti-HAV seropositivity rates, Anti-HAV geometric mean concentrations and 3 more.
02
Drugs
Hepatitis A virus vaccineacellular pertussis vaccinehaemophilus influenzae type b vaccine
03
Conditions
hepatitis A (HAV)diphtheriaTetanuspertussisHaemophilus influenzae type b disease (Hib)
Beyond the preview
Go deeper on 2015-001530-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-001530-25.